NFKB1 and acute lymphoblastic leukemia: In summary, we observed a direct association between the overexpression of the NF-κB pathway and a poorer clinical response to MTX, as well as between the overexpression of NF-κB genes, the activation of NF-κB by TNF-α, MTX resistance, and reduced cell proliferation in a panel of ALL cell lines.